Tamsulosin Hydrochloride Capsule
Product Images NDC 68071-4443

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 68071-4443). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 4443 9

NuCare Pharmaceuticals, Inc. presents Tamsulosin HCI 0.4mg capsules in a lot of 90 units, presented in an olive green opaque/orange oblong capsule imprinted with "D", "Exp. Date", and "Lot#: 000000". Each capsule contains TansosinHC USP 0.4mg with GTIN 0036807144391 and a Serial# 00000000002. The Manufacturer NDC is 65862-598-05, and the product is RX only, with a warning to keep out of reach of children and stored at a controlled temperature of 68-77°F. Contact the doctor for medical advice about side effects or report them to the FDA at 1-800-FDA-1088.*

FDA Label Image

Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-dose Administration Of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted And Fed Conditions (n=8) (Tamsulosin Fig1)

FDA Label Image

Figure 2a Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 1 (Tamsulosin Fig2)

The image shows a graph representing the mean change from baseline in Total AUA Symptom Score in a study with two treatment options: an 0.08mg dose of a certain substance and a placebo. The x-axis indicates the duration of the treatment in weeks and the y-axis shows the mean change score from 0 to 35. There are multiple data points for each treatment option, ranging from week 0 to week 13, and the last data point shows the LOCF (last observation carried forward) value.*

FDA Label Image

Figure 2b Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 2 (Tamsulosin Fig3)

This is a figure displaying the mean change from baseline in the Total American Urological Association (AUA) Symptom Score on a scale of 0 to 35, in Study 2. The graph shows the value for different treatments including O=0O—0-08mg LNt 0.4mg, 3 Placebo with the duration of treatment in weeks being displayed on the X-axis. It also shows the number of participants for each treatment option.*

FDA Label Image

Figure 3a Mean Increase In Peak Urine Flow Rate (ml/sec) Study 1 (Tamsulosin Fig4)

The image shows a graph titled "Mean Increase in Peak Urine Flow Rate (in L/Sec) Study 1". The graph displays the peak urine flow rate in mL/sec for different treatments, including two different dosages (0.08mg and 0.4mg) and a placebo group. The mean change in urine flow rate is shown on the y-axis, and the duration of treatment in weeks is shown on the x-axis. The graph includes four data points for each treatment group, with sample sizes ranging from 617 to 755.*

FDA Label Image

Figure 3b Mean Increase In Peak Urine Flow Rate (ml/sec) Study 2 (Tamsulosin Fig5)

FDA Label Image

Chemical Structure (Tamsulosin Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.